These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3065728

  • 1. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
    Karray S, Emilie D, Galanaud P.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
    [Abstract] [Full Text] [Related]

  • 2. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
    Lasky JL, Thorbecke GJ.
    Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
    [Abstract] [Full Text] [Related]

  • 3. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
    Hivroz C, Grillot-Courvalin C, Labaume S, Miglierina R, Brouet JC.
    Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
    [Abstract] [Full Text] [Related]

  • 4. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response.
    Karray S, Delfraissy JF, Merle-Beral H, Wallon C, Debre P, Galanaud P.
    J Immunol; 1988 Feb 01; 140(3):774-8. PubMed ID: 3257503
    [Abstract] [Full Text] [Related]

  • 5. Induction of differentiation in human leukemic B cells by interleukin 2 alone: differential effect on the expression of mu and J chain genes.
    Emilie D, Karray S, Merle-Béral H, Debré P, Galanaud P.
    Eur J Immunol; 1988 Oct 01; 18(10):1479-83. PubMed ID: 3142777
    [Abstract] [Full Text] [Related]

  • 6. Regulatory effects of IL-4 on human B-cell response to IL-2.
    Galanaud P, Karray S, Llorente L.
    Eur Cytokine Netw; 1990 Oct 01; 1(2):57-64. PubMed ID: 2102812
    [Abstract] [Full Text] [Related]

  • 7. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.
    Nerl C, Janssen O, Kabelitz D.
    Leukemia; 1988 Dec 01; 2(12 Suppl):50S-56S. PubMed ID: 3059076
    [Abstract] [Full Text] [Related]

  • 8. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
    Hivroz C, Vallé A, Brouet JC, Banchereau J, Grillot-Courvalin C.
    Eur J Immunol; 1989 Jun 01; 19(6):1025-30. PubMed ID: 2526738
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
    Ghaderi AA, Richardson P, Cardona C, Millsum MJ, Ling N, Gillis S, Ledbetter J, Gordon J.
    Leukemia; 1988 Mar 01; 2(3):165-70. PubMed ID: 3126369
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory influence of IL-4 on human B cell responsiveness.
    Jelinek DF, Lipsky PE.
    J Immunol; 1988 Jul 01; 141(1):164-73. PubMed ID: 2837507
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
    Carlsson M, Tötterman TH, Rosén A, Nilsson K.
    Leukemia; 1989 Aug 01; 3(8):593-601. PubMed ID: 2787454
    [Abstract] [Full Text] [Related]

  • 12. Human T cell-replacing factor(s): a comparison of recombinant and purified human B cell growth and differentiation factors.
    Smith SH, Shields JG, Callard RE.
    Eur J Immunol; 1989 Nov 01; 19(11):2045-9. PubMed ID: 2689186
    [Abstract] [Full Text] [Related]

  • 13. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
    Carlsson M, Matsson P, Rosén A, Sundström C, Tötterman TH, Nilsson K.
    Leukemia; 1988 Nov 01; 2(11):734-44. PubMed ID: 3263557
    [Abstract] [Full Text] [Related]

  • 14. A further characterization of B-CLL lymphocytes: phenotypic and functional studies.
    Merle-Béral H.
    Nouv Rev Fr Hematol (1978); 1990 Nov 01; 32(5):319-21. PubMed ID: 2099403
    [Abstract] [Full Text] [Related]

  • 15. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
    Vazquez A, Auffredou MT, Gerard JP, Delfraissy JF, Galanaud P.
    J Immunol; 1987 Oct 01; 139(7):2344-8. PubMed ID: 3116080
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
    Petit-Koskas E, Génot E, Lawrence D, Kolb JP.
    Eur J Immunol; 1988 Jan 01; 18(1):111-6. PubMed ID: 3257917
    [Abstract] [Full Text] [Related]

  • 20. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P, Zelen I, Ristic P, Baskic D, Popovic S, Arsenijevic N.
    Arch Med Res; 2009 Jul 01; 40(5):357-63. PubMed ID: 19766898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.